Technical Analysis for GSK - GlaxoSmithKline PLC

Grade Last Price % Change Price Change
F 35.34 1.45% 0.51
GSK closed down 0.85 percent on Friday, February 3, 2023, on 74 percent of normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Flat Flat

Date Alert Name Type % Chg
50 DMA Resistance Bearish 1.45%
Fell Below 20 DMA Bearish 1.45%
Expansion Pivot Sell Setup Bearish Swing Setup 1.45%
Bollinger Band Squeeze Range Contraction 1.45%
Gapped Up Strength 1.45%
Fell Below 50 DMA Bearish 0.58%
20 DMA Support Bullish 0.58%
Bollinger Band Squeeze Range Contraction 0.58%
Earnings Movers Other 0.58%
20 DMA Support Bullish -0.44%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Possible NR7 about 2 hours ago
Possible Inside Day about 2 hours ago
Gap Up Partially Closed about 7 hours ago
1.5x Volume Pace about 7 hours ago
Rose Above 20 DMA about 7 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


GlaxoSmithKline PLC Description

GlaxoSmithKline plc, together with its subsidiaries, discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. It also produces paediatric and adult vaccines to prevent a range of infectious diseases, including hepatitis A and B; diphtheria, tetanus, and whooping cough; measles, mumps, and rubella; polio; typhoid; influenza; and bacterial meningitis. In addition, it provides consumer health products in oral care, nutritional, total wellness, and skin health areas. The company's total wellness products include Panadol for the treatment of paracetamol-based treatment of headache and joint pain, fever, and cold symptoms; NicoDerm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to quitting smoking; ENO Tums, a rapid relief antacid; and oral care products comprise Sensodyne for the prevention of dental sensitivity; Polident, Poligrip, and Corega to improve comfort of fitted dentures and to clean dentures; Aquafresh for the prevention of caries, gum disease, and bad breath; and Parodontax to help stop bleeding gums and gum health. Its nutrition products include Lucozade for energy and hydration; and Horlicks and Maxinutrition for nutrition; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, and Oilatum, a soothing treatment for eczema and dry skin conditions. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.


Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: Medicine Cancer Pharmaceutical Acid Drugs Infectious Diseases Pharmaceutical Products Medication Rare Diseases Inflammation Infection Antibiotics Health Products Influenza Dermatology Asthma Depression HIV Nutrition Products Smoking Fever Smoking Cessation Cough Nicotine Wellness Products Headache Oral Care Products Body Care Products Meningitis Paracetamol Antacid Eczema Hepatitis A Measles Preventive Healthcare Consumer Health Products Joint Pain Mumps Rubella

Is GSK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 46.97
52 Week Low 28.465
Average Volume 4,918,611
200-Day Moving Average 37.15
50-Day Moving Average 35.18
20-Day Moving Average 35.14
10-Day Moving Average 35.17
Average True Range 0.58
RSI 46.24
ADX 19.83
+DI 22.25
-DI 18.21
Chandelier Exit (Long, 3 ATRs) 34.05
Chandelier Exit (Short, 3 ATRs) 35.97
Upper Bollinger Bands 35.75
Lower Bollinger Band 34.53
Percent B (%b) 0.24
BandWidth 3.47
MACD Line 0.05
MACD Signal Line 0.09
MACD Histogram -0.0421
Fundamentals Value
Market Cap 87.38 Billion
Num Shares 2.51 Billion
EPS 0.99
Price-to-Earnings (P/E) Ratio 35.11
Price-to-Sales 2.06
Price-to-Book 4.88
PEG Ratio 11.18
Dividend 2.03
Dividend Yield 5.83%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.99
Resistance 3 (R3) 36.10 35.81 35.80
Resistance 2 (R2) 35.81 35.52 35.76 35.73
Resistance 1 (R1) 35.32 35.33 35.18 35.22 35.67
Pivot Point 35.04 35.04 34.97 34.99 35.04
Support 1 (S1) 34.55 34.74 34.41 34.44 33.99
Support 2 (S2) 34.26 34.56 34.21 33.93
Support 3 (S3) 33.77 34.26 33.86
Support 4 (S4) 33.67